AQR Capital Management - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$17,602,201
-0.2%
196,497
-5.1%
0.04%
-2.7%
Q2 2023$17,630,876
+43.7%
207,081
+38.7%
0.04%
+37.0%
Q1 2023$12,267,241
+164.5%
149,291
+152.2%
0.03%
+145.5%
Q4 2022$4,638,242
+48.2%
59,199
+40.0%
0.01%
+37.5%
Q3 2022$3,130,000
+550.7%
42,283
+468.8%
0.01%
+700.0%
Q2 2022$481,000
-70.0%
7,434
-71.1%
0.00%
-66.7%
Q1 2022$1,606,000
+331.7%
25,713
+266.9%
0.00%
+200.0%
Q4 2021$372,000
-92.4%
7,009
-89.9%
0.00%
-88.9%
Q3 2021$4,887,000
-18.8%
69,225
-24.0%
0.01%
-10.0%
Q2 2021$6,019,000
+55.8%
91,095
+161.7%
0.01%
+66.7%
Q1 2021$3,864,000
-43.3%
34,808
-39.5%
0.01%
-50.0%
Q4 2020$6,819,000
-2.3%
57,514
-29.0%
0.01%0.0%
Q3 2020$6,978,000
+36.4%
81,041
+38.8%
0.01%
+50.0%
Q2 2020$5,115,000
+18.2%
58,401
+34.4%
0.01%
+14.3%
Q1 2020$4,329,000
-75.2%
43,437
-71.4%
0.01%
-65.0%
Q4 2019$17,430,000
-53.8%
151,701
-49.3%
0.02%
-54.5%
Q3 2019$37,729,000
-52.9%
299,101
-55.5%
0.04%
-50.6%
Q2 2019$80,159,000
-15.4%
671,631
-38.0%
0.09%
-11.9%
Q1 2019$94,785,000
+9.1%
1,083,510
+24.8%
0.10%0.0%
Q4 2018$86,889,000
+69.4%
868,456
+93.9%
0.10%
+106.1%
Q3 2018$51,307,000
+222.1%
447,783
+152.1%
0.05%
+206.2%
Q2 2018$15,930,000
+128.2%
177,626
+86.2%
0.02%
+100.0%
Q1 2018$6,981,000
+957.7%
95,413
+740.2%
0.01%
+700.0%
Q4 2017$660,000
+208.4%
11,356
+138.4%
0.00%
Q3 2017$214,000
-35.7%
4,764
-41.9%
0.00%
Q1 2017$333,000
+0.9%
8,2020.0%0.00%
Q4 2016$330,000
-80.1%
8,202
-82.1%
0.00%
-100.0%
Q3 2016$1,661,000
+32.1%
45,889
+5.8%
0.00%
+50.0%
Q2 2016$1,257,000
+363.8%
43,359
+416.4%
0.00%
+100.0%
Q3 2015$271,000
-55.2%
8,397
-42.6%
0.00%0.0%
Q2 2015$605,000
+136.3%
14,619
+135.8%
0.00%0.0%
Q2 2013$256,000
+1.2%
6,2000.0%0.00%0.0%
Q4 2012$253,0006,2000.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders